v.1.0 Date: December 2015 Cathy Riley - Director of Pharmacy Policy and Procedures Committee Policy and Procedures Committee

Size: px
Start display at page:

Download "v.1.0 Date: December 2015 Cathy Riley - Director of Pharmacy Policy and Procedures Committee Policy and Procedures Committee"

Transcription

1 Clinical Preparation and administration of Controlled Drugs against a prescription SOP Document Control Summary Status: Replacement Controlled Drug Policy Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date: Key Words: Associated Policy or Standard Operating Procedures v.1.0 Date: December 2015 Cathy Riley - Director of Pharmacy Policy and Procedures Committee Policy and Procedures Committee Date: Date: Medicines Optimisation Strategy : Making the most of medicines February 2016 December 2018 Controlled Drugs Medicines Code 18/02/ /02/2016 Contents 1. Introduction Purpose Scope Procedure Process For Monitoring Compliance And Effectiveness References... 5

2 Change Control Amendment History Version Dates Amendments v.01 December 15 SOP Page 2 of 5

3 1. Introduction SOP applies to all clinical areas of South Staffordshire & Shropshire Healthcare Foundation Trust, except prisons and community substance misuse teams which have individual SOPs developed. 2. Purpose To ensure the accurate prescription validation and preparation of the dose of controlled drug prior to administration of the CD and the subsequent entry into the CD register. 3. Scope This SOP covers: Validation of the prescription Preparation of the dose against the prescription Entry into the CD register of doses administered/supplied 4. Procedure Validation of the prescription It must not be assumed that the person prescribing the CD is authorised to do so. Care must be taken by staff to ensure as far as reasonably possible that the prescription is valid. NB FY1 doctors are not able to prescribe Schedule 2 or 3 CDs for leave, discharge or for out-patients. If in doubt of the validity of the signature, steps must be taken in order to verify their authority to prescribe. Preparation and administration of the dose against the prescription The procedure for administration of a CD is the same as for other Medicines as laid down in the Trust s Medicines Code. In addition: The person administering must be aware of the following characteristics of the medicine and formulation: usual starting dose, frequency of administration, standard dosing increments, symptoms of overdose and common side effects. When a dose increase is prescribed, the calculated dose should be checked to ensure that it is safe for the patient, not normally more than 50% higher than the previous dose.(see section (2) Any dose that appears to be unusual should be confirmed with the prescriber. Page 3 of 5

4 The administration of any controlled drug requires double checking by another authorised employee (ideally and usually a registered nurse Where two authorised employees are involved in the administration of CDs, one of them must be a designated practitioner (registered nurse). Both should be present during the whole of the administration procedure. They should both witness: o The preparation of the CDs to be administered. o The CD being administered to the patient. o The wastage/destruction of any surplus drug (e.g. part of an ampoule infusion not required). A record should be made in the ward or department CD Record Book when a schedule 2 CD (or Buprenorphine used for substance misuse/subutex) is removed from the CD cupboard. Both staff must have seen a valid prescription for the CD Liquid CDs can often be marginally out due to small but repeated errors in the measuring process, causing problems on reconciliation. This can be reduced by using the smallest measuring device possible e.g. oral syringes for lower doses. Staff administering CDs must be competent to recognise and treat any patient deterioration and/or any known adverse effect that required immediate life support intervention, such as anaphylaxis, cardiovascular collapse, and respiratory depression. Substance misuse patients may need close supervision of their doses to ensure that they have actually taken the medication. Staff should be aware of those that need extra scrutiny and the consequences of incomplete administration Entry into the CD register of doses administered/supplied Details of the administration for Schedule 2 CDs and Buprenorphine used for substance misuse/subutex must be recorded in the ward CD Record Book, together with a full signature of both the witness and the person who administered the drug. The Record Book must be completed immediately following the administration of the CD. Any dose of a Schedule 2 Controlled Drug or Buprenorphine used for substance misuse (Subutex) that is prepared but not administered, including partly used syringes used in syringe driver pumps shall be destroyed on the ward or department. It shall be destroyed in the presence of the witness and a record made in the CD Register, to that effect stating the amount administered and the amount wasted, which includes the signatures of the 2 practitioners involved in the destruction. It should be rendered irretrievable by emptying into a sharps bin. The emptied vial or ampoule should then also be placed in the sharps bin. Page 4 of 5

5 When the bin is sent for destruction it should be labelled contains mixed pharmaceutical waste and sharps for incineration 5. Process for Monitoring Compliance and Effectiveness Audits relating to different aspects of the CD SOPs will be carried out at regular intervals as part of the ward CD audit and annual medicines management audit. 6. References Page 5 of 5

Medicines Optimisation Strategy

Medicines Optimisation Strategy Clinical Reducing Dosing Errors with Opioid Medicines (Controlled Drug SOP): Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic

More information

Controlled Drugs Accountable Officers Network Scotland Executive Group. Gabapentin and Pregabalin - Frequently Asked Questions

Controlled Drugs Accountable Officers Network Scotland Executive Group. Gabapentin and Pregabalin - Frequently Asked Questions Gabapentin and Pregabalin - Frequently Asked Questions Gabapentin and pregabalin will become Schedule 3 Controlled Drugs in April 2019 NHS Contractor Services Prescribers are legally permitted to be in

More information

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices Name of Dental Practice : Objectives To ensure implementation of the regulations and guidance on safe and secure handling of midazolam and other controlled drugs (CDs) Scope To cover all aspects of obtaining

More information

Document Details. Patient Group Direction

Document Details. Patient Group Direction Document Details Title Patient Group Direction (PGD) Hepatitis B Vaccine (Engerix ) Trust Ref No 1505-41182 Local Ref (optional) Main points the Immunisation against Hepatitis B document covers Who is

More information

Storage, recording & disposal of Schedule 2 Controlled Drugs. Dr. Jo Murrell BVSc. (hons), PhD, DiplECVAA, MRCVS

Storage, recording & disposal of Schedule 2 Controlled Drugs. Dr. Jo Murrell BVSc. (hons), PhD, DiplECVAA, MRCVS Storage, recording & disposal of Schedule 2 Controlled Drugs Dr. Jo Murrell BVSc. (hons), PhD, DiplECVAA, MRCVS All Controlled Drugs are listed in one of the five Schedules in the Misuse of Drugs Regulations

More information

South Staffordshire and Shropshire Healthcare NHS Foundation Trust

South Staffordshire and Shropshire Healthcare NHS Foundation Trust South Staffordshire and Shropshire Healthcare NHS Foundation Trust Document Version Control Document Type and Title: Authorised Document Folder: Immunisation Policy YELLOW - Clinical New or Replacing:

More information

Re: Handling of gabapentin and pregabalin as Schedule 3 Controlled Drugs in health and justice commissioned services

Re: Handling of gabapentin and pregabalin as Schedule 3 Controlled Drugs in health and justice commissioned services To: Health and justice commissioners and providers Public Health England health and justice leads Her Majesty s Prison and Probation Service Home Office immigration removal centre leads Health and justice

More information

Curraheen, Co.Cork. Disclaimer: The information contained within this policy is accurate and up-to-date at date of approval.

Curraheen, Co.Cork. Disclaimer: The information contained within this policy is accurate and up-to-date at date of approval. Curraheen, Co.Cork. SOP Title: Management of Transdermal Patches SOP No: 19 Version number: 2 Date of Re-approval: 28 th July, 2015 Revision due: 28 th July, 2018 Index Code No: CLIN041/SOP NO 19 Disclaimer:

More information

PATIENT SAFETY ALERT

PATIENT SAFETY ALERT PATIENT SAFETY ALERT PROBLEM: Research in UK and elsewhere has identified a risk to patients from errors occurring during intravenous administration of potassium solutions. Potassium chloride concentrate

More information

Developed By Name Signature Date

Developed By Name Signature Date Patient Group Direction 2155 version 2.0 Administration / Supply of Inhaled Salbutamol in Asthma by Registered Practitioners employed by Torbay and South Devon NHS Foundation Trust Date of Introduction:

More information

Document Details Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No Local Ref (optional) Main points the

Document Details Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No Local Ref (optional) Main points the Document Details Title Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No 1506-41174 Local Ref (optional) Main points the Active immunisation against infection caused by Hepatitis

More information

Contributes to CQC Outcome number: 9&12 Consulted With Post/Committee/Group Date. Pharmacist. Alison Felton Head of Pharmacy/Deputy Chief.

Contributes to CQC Outcome number: 9&12 Consulted With Post/Committee/Group Date. Pharmacist. Alison Felton Head of Pharmacy/Deputy Chief. Prescribing paracetamol in adult inpatients at MEHT Type: Clinical Guideline Register No: 18005 Status: Public on ratification Developed in response to: In line with Basildon Contributes to CQC Outcome

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Pre-filled Patient Controlled Analgesia (PCA) syringes

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Pre-filled Patient Controlled Analgesia (PCA) syringes The Newcastle upon Tyne Hospitals NHS Foundation Trust Pre-filled Patient Controlled Analgesia (PCA) syringes Version.: 2.2 Effective From: 1 June 2016 Expiry Date: 1 June 2019 Date Ratified: 20 April

More information

PATIENT GROUP DIRECTION (PGD)

PATIENT GROUP DIRECTION (PGD) PATIENT GROUP DIRECTION (PGD) SUPPLY OF NALOXONE HYDROCHLORIDE INJECTION BY REGISTERED NURSES TO CLIENTS BEING RELEASED FROM HMP FORD Version Number: 01HMP Patient Group Direction originally drawn up by:

More information

Safe Management of Controlled Drugs

Safe Management of Controlled Drugs Definitions Safe Management of Controlled Drugs Controlled drugs Any drug listed in any schedule of the Misuse of Drugs Act refer to Appendix 1 Introduction This protocol describes the procedures in place

More information

Document Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml

Document Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml Title Document Details Patient Group Direction (PGD) Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml Trust Ref No 1445-36348 Local Ref (optional) Main points the document The treatment of

More information

Guidance on Bulk Prescribing for Care Home Patients

Guidance on Bulk Prescribing for Care Home Patients Guidance on Bulk Prescribing for Care Home Patients Introduction Many patients in care homes taking medicines when required (PRN) can inevitably present problems for the prescriber in determining the quantity

More information

Medication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016

Medication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016 Medication Safety Patient Safety Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016 1 The patient journey Admission Ward Transfer Ward stay Discharge Medication storage and supply

More information

Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04

Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04 Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04 Date issued Issue 1 Nov 2018 Planned review Nov 2021 PPT-PGN 18 part of NTW(C)38 Pharmaceutical

More information

Developed By Name Signature Date

Developed By Name Signature Date Patient Group Direction 2156 version 2.0 Administration of Ipratropium 250mcg/ml Nebuliser Solution in Acute Asthma by Registered Practitioners employed by Torbay and South Devon NHS Foundation Date of

More information

Policy for the safe use of oral methotrexate

Policy for the safe use of oral methotrexate Policy for the safe use of oral methotrexate Policy Checklist Name of Policy: Purpose of Policy: Directorate responsible for Policy Name & Title of Author: Does this meet criteria of a Policy? Staff side

More information

PGD5717. Director of Quality & Clinical Performance. Therèsa Moyes

PGD5717. Director of Quality & Clinical Performance. Therèsa Moyes PGD5717 Patient Group Direction Administration of Nicotine Lozenges 4mg, Sublingual Tablets 2mg or Mouth Spray By Registered Nurses employed as by South Staffordshire & Shropshire Healthcare Foundation

More information

Guidance for the Handling of Tramadol in Health and Justice Residential Settings in Wales

Guidance for the Handling of Tramadol in Health and Justice Residential Settings in Wales Iechyd Cyhoeddus Ffarmacolegol Pharmaceutical Public Health / Guidance for the Handling of Tramadol in Health and Justice Residential Settings in Wales 13 October 2015 Author: Rosemary Allgeier Guidance

More information

concentrate intravenous solution and other strong potassium solutions

concentrate intravenous solution and other strong potassium solutions Policy for the use of potassium chloride concentrate intravenous solution and other strong potassium solutions CLINICAL GUIDELINES ID TAG Policy for the use of potassium chloride Title: concentrate intravenous

More information

Document Details. Patient Group Direction

Document Details. Patient Group Direction Document Details Title Patient Group Direction (PGD) Salbutamol Aerosol Inhaler and salbutamol Nebulised Solution Trust Ref No 1569-34313 Local Ref (optional) Main points the document Treatment of acute

More information

Procedure Reviewed By: Narinder Sangha Deputy Chief Pharmacist STANDARD OPERATING PROCEDURE

Procedure Reviewed By: Narinder Sangha Deputy Chief Pharmacist STANDARD OPERATING PROCEDURE Written By: Objective By: ed By: To ensure safe and consistent working practice throughout Black Country Partnership Foundation Trust (BCPFT) and to avoid unnecessary harm to patients on lithium therapy

More information

Administration of Injectable Medication by Healthcare Assistants (Band 3) Standard Operating Procedure

Administration of Injectable Medication by Healthcare Assistants (Band 3) Standard Operating Procedure Administration of Injectable Medication by Healthcare Assistants (Band 3) Standard Operating Procedure DOCUMENT CONTROL: Version: 1 Ratified by: Quality Assurance Sub Committee Date ratified: 4 September

More information

Introduction. Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients)

Introduction. Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients) Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients) Introduction This guideline is designed to provide a framework for patients to administer

More information

ADMINISTRATION OF INSULIN

ADMINISTRATION OF INSULIN STANDARD OPERATING PROCEDURE ADMINISTRATION OF INSULIN Issue History First issued April 2012 Issue Version Two Purpose of Issue/Description of Change Planned Review Date To promote the safe administration

More information

POLICY FOR THE SAFE USE OF ORAL METHOTREXATE IN SECONDARY CARE. September 2011

POLICY FOR THE SAFE USE OF ORAL METHOTREXATE IN SECONDARY CARE. September 2011 POLICY FOR THE SAFE USE OF ORAL METHOTREXATE IN SECONDARY CARE September 2011 WHSCT Policy for the safe use of oral methotrexate in secondary care Page 1 of 8 Policy Title Policy for the safe use of oral

More information

1. Intrathecal must never be abbreviated to IT on a prescription form True / False

1. Intrathecal must never be abbreviated to IT on a prescription form True / False Appendix 1: Intrathecal SACT Assessment Questions Core General Questions must be completed by all staff. 1. Intrathecal must never be abbreviated to IT on a prescription form 2. Intrathecal SACT must be

More information

Effective Shared Care Agreement for the treatment of severe motor complications in people with Parkinson Disease with apomorphine (APO-go )

Effective Shared Care Agreement for the treatment of severe motor complications in people with Parkinson Disease with apomorphine (APO-go ) Effective Shared Care Agreement for the treatment of severe motor complications in people with Parkinson Disease with apomorphine (APO-go ) This shared care agreement outlines the ways in which the responsibilities

More information

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS The benefits of prefilled syringes for palliative care from the hospital pharmacy service In

More information

patient group direction

patient group direction SALBUTAMOL v01 1/12 SALBUTAMOL PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic) Emergency Care Practitioner

More information

Patient Group Direction for Measles, Mumps & Rubella Vaccine. PGD Version No.: 7/2013.

Patient Group Direction for Measles, Mumps & Rubella Vaccine. PGD Version No.: 7/2013. Document Title: Patient Group Direction for Measles, Mumps & Rubella Vaccine Area Team Doc Ref.: PGD Version No.: 7/2013 Doc Ref.: http://www.england.nhs.uk/mids-east/ss-at/immunisations/ Author: Owner:

More information

PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017

PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017 PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017 NAME OF PROCEDURE: Medicines Procedure: Patient Group Directions for the Administration of Hepatitis B Vaccine for SABP Drug and Alcohol Teams. PURPOSE OF PROCEDURE:

More information

Patient Group Directions Policy

Patient Group Directions Policy Patient Group Directions Policy Category: Summary: Equality Analysis undertaken: Valid From: Date of Next Review: Approval Date/ Via: Distribution: Related Documents: Author(s): Further Information: This

More information

Healthcare (clinical) Waste Awareness

Healthcare (clinical) Waste Awareness Healthcare (clinical) Waste Awareness Disposal of Dental Service Waste Dental services in NHS Boards, where applicable, can now use the healthcare (clinical) waste service provided by the NHS Board for

More information

Dispensing and administration of emergency opioid antagonist without a

Dispensing and administration of emergency opioid antagonist without a 68-7-23. Dispensing and administration of emergency opioid antagonist without a prescription. (a) A pharmacist may dispense an FDA-approved emergency opioid antagonist and the necessary medical supplies

More information

AUSTRALIAN AND NEW ZEALAND COLLEGE OF ANAESTHETISTS ABN

AUSTRALIAN AND NEW ZEALAND COLLEGE OF ANAESTHETISTS ABN PS51 (2009) AUSTRALIAN AND NEW ZEALAND COLLEGE OF ANAESTHETISTS ABN 82 055 042 852 GUIDELINES FOR THE SAFE ADMINISTRATION OF INJECTABLE DRUGS IN ANAESTHESIA 1. INTRODUCTION 1.1 Current data suggest that

More information

Procedure for the prescribing and administration of insulin

Procedure for the prescribing and administration of insulin Procedure for the prescribing and administration of insulin Author: Lilian Baxendale and Heather Beadle Designation: Clinical Governance Pharmacists Version: Version 3 Date: December 2016 Date Approved:

More information

North of England Cancer Network. Policies and Procedures. Standards for the Safe Use of Oral Anticancer Medicines

North of England Cancer Network. Policies and Procedures. Standards for the Safe Use of Oral Anticancer Medicines \ North of England Cancer Network Policies and Procedures Standards for the Safe Use of Oral Anticancer Medicines NECN Oral Anticancer medicine Policy version 1.6 Page 1 of 17 Issue Date: Feb 2017 Contents

More information

Clinician Responsible for Training and Review: Emergency Department Consultant

Clinician Responsible for Training and Review: Emergency Department Consultant Patient Group Direction for the supply and/or administration of Paracetamol Oral Suspension 250mg/5ml (Paracetamol paediatric suspension) to children receiving treatment from NHS Borders services. This

More information

Clinician Responsible for Training and Review: Emergency Department Consultant

Clinician Responsible for Training and Review: Emergency Department Consultant Patient Group Direction for the Supply of Salbutamol Inhaler to patients receiving treatment from NHS Borders Emergency Department/Out of Hours/Minor Injury Units This document authorises the supply or

More information

Canadian National Medical Marijuana Association (CNMMA)

Canadian National Medical Marijuana Association (CNMMA) Canadian National Medical Marijuana Association (CNMMA) Our Mission Is to ensure all Canadian patients who benefit from medical marijuana, have access to the highest quality of product and services, to

More information

NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION

NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION Chapter NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION EFFECTIVE: Policy REVISED: 4/13/9 draft NALOXONE DISTRIBUTION POLICY I. PURPOSE: This New Mexico Department of Health (NMDOH)

More information

Unofficial translation /Ministry of Social Affairs and Health. No. 548/2008. Government Decree on Narcotics Control

Unofficial translation /Ministry of Social Affairs and Health. No. 548/2008. Government Decree on Narcotics Control Unofficial translation /Ministry of Social Affairs and Health No. 548/2008 Government Decree on Narcotics Control Issued in Helsinki on 28 August 2008 Section 1 Scope of application This Decree lays down

More information

Initiation of Clozapine Treatment Community Patients

Initiation of Clozapine Treatment Community Patients Initiation of Clozapine Treatment Community Patients Who Should Read This Policy Target Audience All clinical staff working in the community N/A N/A Initiation of Clozapine Treatment for Patients in the

More information

ASPMN Conference Baltimore, Maryland

ASPMN Conference Baltimore, Maryland ASPMN Conference Baltimore, Maryland Prescribing Controlled Substances Managing Risk and Optimizing Outcomes September 13, 2012 Tracey Fremd, NP Tracey Fremd Consulting, Inc. Most Common Uses for Controlled

More information

USE OF UNLICENSED MEDICINES AND OFF-LABEL MEDICINES WHERE A LICENSED MEDICINE IS AVAILABLE

USE OF UNLICENSED MEDICINES AND OFF-LABEL MEDICINES WHERE A LICENSED MEDICINE IS AVAILABLE NHS Scotland Directors of Pharmacy and Scottish Association of Medical Directors USE OF UNLICENSED MEDICINES AND OFF-LABEL MEDICINES WHERE A LICENSED MEDICINE IS AVAILABLE CONSENSUS STATEMENT This consensus

More information

Portsmouth Intensive Care Emergency Anaesthetic Drug Pack (EADP)

Portsmouth Intensive Care Emergency Anaesthetic Drug Pack (EADP) Portsmouth Intensive Care Emergency Anaesthetic Drug Pack (EADP) Authors: Joe Tooley, Keith Ritchie, Caroline Cawkill, Steve Mathieu 17/02/17 1 TABLE OF CONTENTS 1. Introduction 2. Purpose 3. Scope 4.

More information

Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian

Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian 1. Introduction The provision of Substance Misuse (SM) services through

More information

SAMPLE. PGD Reviewed by: Chris Faldon, John Maloney, Tim Patterson, Adrian MacKenzie, Claire Stein

SAMPLE. PGD Reviewed by: Chris Faldon, John Maloney, Tim Patterson, Adrian MacKenzie, Claire Stein Patient Group Direction for the supply or administration of haemophilus influenzae type B and meningococcal conjugate vaccine to children requiring immunisation as part of the national childhood vaccination

More information

Community Psychiatric Nurse. Consultant Psychiatrist, Substance Misuse Services

Community Psychiatric Nurse. Consultant Psychiatrist, Substance Misuse Services PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF HEPATITIS A VACCINE (HAVRIX MONODOSE VACCINE) BY REGISTERED NURSES WORKING IN THE COMMUNITY SUBSTANCE MISUSE TEAMS Version Number : 2 Patient Group

More information

1. TOPICAL MORPHINE FOR PAINFUL WOUNDS

1. TOPICAL MORPHINE FOR PAINFUL WOUNDS 1. TOPICAL MORPHINE FOR PAINFUL WOUNDS 1.1. Scope Nursing staff caring for palliative adult patients with painful wounds in the community and on the wards. 1.2. Procedure / Guideline Indication For use

More information

Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients

Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients Pharmaceutical Society of Ireland Version 3 October 2017 Updates made following the enactment

More information

Summary of Significant Changes at this Revision. Items Required

Summary of Significant Changes at this Revision. Items Required Update Approver/checker Summary of Significant Changes at this Revision Purpose and Scope Items Required 1. The Abbott FreeStyle Optium meter is a battery-powered device designed for the measurement of

More information

Monash University Procedure. High Risk Scheduled Drugs and Poisons Procedure (S8/9/11)

Monash University Procedure. High Risk Scheduled Drugs and Poisons Procedure (S8/9/11) Monash University Procedure Procedure Title Parent Policy High Risk Scheduled Drugs and Poisons Procedure (S8/9/11) OHS Policy Date Effective 19 September 2017 Review Date September 2020 Procedure Owner

More information

Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical Commissioning Group

Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical Commissioning Group BEFORE USING THIS POLICY ALWAYS ENSURE YOU ARE USING THE MOST UP TO DATE VERSION Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical

More information

SAMPLE. This direction was authorised on 4/5/2007. The direction will be reviewed by 4/5/2009

SAMPLE. This direction was authorised on 4/5/2007. The direction will be reviewed by 4/5/2009 Patient Group Direction for the Supply and Administration of Flumazenil 100microgram Injection To Patients requiring reversal of oversedation due to midazolam in association withendoscopy attending Endoscopy

More information

New regulatory requirements DPCS Regulations 2017

New regulatory requirements DPCS Regulations 2017 New regulatory requirements DPCS Regulations 2017 Prescribers and pharmacists May 2017 Table of Contents Explanatory notes... 1 Clarifying the meaning of key terms... 1 Chart instructions and prescriptions...

More information

ADVANCE PREPARATION OF INSULIN FOR PATIENTS TO ADMINISTER AT HOME

ADVANCE PREPARATION OF INSULIN FOR PATIENTS TO ADMINISTER AT HOME STANDARD OPERATING PROCEDURE ADVANCE PREPARATION OF INSULIN FOR PATIENTS TO ADMINISTER AT HOME First Issued July 08 Issue Version Two Purpose of Issue/Description of Change Planned Review Date To promote

More information

Patient Group Direction (PGD)

Patient Group Direction (PGD) Patient Group Direction (PGD) Supply of Nitrofurantoin for uncomplicated Urinary Tract Infections in females aged 16 years and over (Telford and Wrekin and Shropshire Pharmacies Only) For the supply of

More information

This document expires on Patient Group Direction No. VI 11

This document expires on Patient Group Direction No. VI 11 Patient Group Direction (PGD) for The Administration of Combined Inactivated Hepatitis A & Hepatitis B Vaccine (Twinrix adult, Twinrix paediatric) to Adults and Children over one year by Registered Nurses

More information

All Saints First School Administering of Medicines Policy

All Saints First School Administering of Medicines Policy All Saints First School Administering of Medicines Policy Success Indicators The following indicators will demonstrate the level of compliance with this policy and its procedures: a) Employees who are

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL GUIDELINES FOR THE DESTRUCTION OF SCHEDULE 6 MEDICINES AND SUBSTANCES This document has been prepared to serve as a recommendation to applicants wishing to destroy any Schedule

More information

DISPENSING OR SELLING NALOXONE. Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug.

DISPENSING OR SELLING NALOXONE. Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug. DISPENSING OR SELLING NALOXONE Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug. UPDATED ON: April 21, 2017 Purpose The intent of this document is to provide

More information

Regulations for the prescribing of Schedule 8 medicines in WA

Regulations for the prescribing of Schedule 8 medicines in WA Regulations for the prescribing of Schedule 8 medicines in WA Pharmaceutical Services Branch V: C20131218AG-2 Aims of presentation To focus Schedule 8 (S8) medication regulations for prescribers on: prescribing

More information

Minister of Social Affairs. Passed No. 73 RTL 2005, 57, 807 Entry into force

Minister of Social Affairs. Passed No. 73 RTL 2005, 57, 807 Entry into force Issuer: Minister of Social Affairs Type: regulation In force from: 12.02.2011 In force until: Did not enter into force Translation published: 08.10.2014 Conditions and Procedure for Handling of Narcotic

More information

Administration of High Dose Intra- Muscular Vitamin Supplements for Patients Undergoing Alcohol Detoxification. Standard Operating Procedure

Administration of High Dose Intra- Muscular Vitamin Supplements for Patients Undergoing Alcohol Detoxification. Standard Operating Procedure Administration of High Dose Intra- Muscular Vitamin Supplements for Patients Undergoing Alcohol Detoxification Standard Operating Procedure DOCUMENT CONTROL: Version: 3 Ratified by: Quality Assurance Sub

More information

Administration of Hepatitis A and B Vaccine

Administration of Hepatitis A and B Vaccine PRACTICE: Ref No: PGD/ONEL/2011/006 Valid from December 2011 Valid to December 2013 Supersedes PGD: Any previous PGD used to administer Twinrix Adult and Paediatric vaccine Professional groups covered

More information

Crowe Healthcare Webinar Series

Crowe Healthcare Webinar Series Crowe Healthcare Webinar Series Healthcare Providers Ongoing Challenges With Controlled Substances Presented by: Scott Gerard, Healthcare Risk Consulting Partner Eric Jolly, Healthcare Risk Vice President

More information

Controlled Drug Process. Khoa Vo Masters candidate University of Canterbury

Controlled Drug Process. Khoa Vo Masters candidate University of Canterbury Controlled Drug Process Khoa Vo Masters candidate University of Canterbury Bachelor of Pharmacy (VN) PG Diploma in Palliative Care (NZ) Cancer Patients in Vietnam 250,000 of 89 million Increased by 150,000

More information

Michigan Opioid Legislation Hospital Compliance Checklist

Michigan Opioid Legislation Hospital Compliance Checklist MHA KEYSTONE CENTER MICHIGAN OPIOID LEGISLATION HOSPITAL COMPLIANCE CHECKLIST The Michigan Opioid Legislation was created by the Michigan Health & Hospital Association to help guide its member hospitals

More information

Requirements for the prescribing of Schedule 4 and Schedule 8 Medicines in Western Australia

Requirements for the prescribing of Schedule 4 and Schedule 8 Medicines in Western Australia Requirements for the prescribing of Schedule 4 and Schedule 8 Medicines in Western Australia Pharmaceutical Services Branch June 2008 1 Key Points Prescribing Schedule 4 medicines (S4s) S4 prescriptions

More information

Today s Presenters. Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care

Today s Presenters. Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care 203 - Monday, April 16, 2018 Today s Presenters Ben Purser Former F.B.I. Special Agent Donna Thiel ProviderTrust Chief

More information

This document expires on Patient Group Direction No. VI 7

This document expires on Patient Group Direction No. VI 7 Patient Group Direction (PGD) for The Administration of Combined low-dose Diphtheria, Tetanus, and Inactivated Polio Vaccine (Revaxis ) to individuals aged over 10 years, by Registered Nurses employed

More information

PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain

PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain Index No: MMG43 PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain Version: 3.1 (Includes anti-emetics and naloxone) Date ratified: July 2013 Ratified by: (Name of Committee) Name

More information

UNIVERSITY POLICY. Revised: Contact:

UNIVERSITY POLICY. Revised: Contact: UNIVERSITY POLICY Policy Name: Policy for Controlled Substances Section #: 90.2.3 Section Title: Compliance Approval Authority: Responsible Executive: Responsible Office: Formerly Book: President Adopted:

More information

AUDIT TOOL FOR SELF INSPECTION OF COMPLIANCE WITH QUALITY MANAGEMENT SYSTEM FOR PATIENT GROUP DIRECTIONS

AUDIT TOOL FOR SELF INSPECTION OF COMPLIANCE WITH QUALITY MANAGEMENT SYSTEM FOR PATIENT GROUP DIRECTIONS AUDIT TOOL FOR DISPENSING SERVICES COMPILED BY: Lynn Morrison ISSUE 1 CHECKED BY: Colette Byrne NUMBER: ISSUE DATE: 01.12.07 SUPERSEDES: NEW REVIEW DATE: 01.12.09 AUDIT TOOL FOR SELF INSPECTION OF COMPLIANCE

More information

Procedure SO:01.08 Administration of medication

Procedure SO:01.08 Administration of medication Document Control Responsible Officer: General Manager, Children s Services Contact Officer: Children s Services Manager Effective Date: July 17, 2017 Procedure Number: SO:01.08 Policy: SO:01 Workplace

More information

What is drug diversion?

What is drug diversion? Learning Objectives Identify the impact of drug diversion on patients and healthcare organizations Explain the common points of risks and methods of drug diversion in healthcare s controlled substance

More information

9/3/2013. Presentation Objective. Prescription Drug Abuse Statistics Prescription Drug Abuse Statistics. Pharmaceutical Drugs and the Environment

9/3/2013. Presentation Objective. Prescription Drug Abuse Statistics Prescription Drug Abuse Statistics. Pharmaceutical Drugs and the Environment Presentation Objective Background - Why do we need a regulation for the disposal of controlled substances. Disposal of Controlled Substances DEA Notice of Proposed Rulemaking AHMP 2013 National Conference

More information

Policy & Procedures Committee Date: 18 January 2018

Policy & Procedures Committee Date: 18 January 2018 Clinical SOP Out-patient Clozapine Initiation Procedure SOP Document Control Summary Status: Replacement supersedes Clozapine Policies and Procedures Version: v1.0 Date: October 2017 Hayley Smart Mo Azar

More information

This document expires on Patient Group Direction No. VI 5

This document expires on Patient Group Direction No. VI 5 Patient Group Direction (PGD) for The Administration of Combined Adsorbed Diphtheria, Tetanus, Pertussis, (Acellular Component) and Inactivated Poliomyelitis Vaccine (Infanrix-IPV ) to children aged between

More information

Consulted With: Post/Committee/Group: Date: John Crome Drug and Alcohol Liaison Emergency Care

Consulted With: Post/Committee/Group: Date: John Crome Drug and Alcohol Liaison Emergency Care THE MANAGEMENT OF OPIOID WITHDRAWAL IN ADULT PATIENTS Type: Clinical Guideline Register No: 18007 Status: Public on ratification Developed in response to: Contributes to CQC Outcome number: 12 Best practice

More information

Asthma Audit Development Project: Hospital pilot information

Asthma Audit Development Project: Hospital pilot information Asthma Audit Development Project: Hospital pilot information Contents Summary... 1 Pilot process summary 1 Introduction and background... 2 What it will cover 2 Timescales 2 Hospital pilot... 3 Why should

More information

Standard Operating Procedure for Use of Opioid Transdermal Patches in homes within NHS Sutton CCG

Standard Operating Procedure for Use of Opioid Transdermal Patches in homes within NHS Sutton CCG Standard Operating Procedure for Use of Opioid Transdermal Patches in homes within NHS Sutton CCG Introduction This procedure is intended to encourage good practice in the management of opioid transdermal

More information

PROCEDURE REFERENCE NUMBER SABP/EXECUTIVE BOARD/0017/PROCEDURE15 PROCEDURE NAME MEDICINES PROCEDURE 15: METHOTREXATE

PROCEDURE REFERENCE NUMBER SABP/EXECUTIVE BOARD/0017/PROCEDURE15 PROCEDURE NAME MEDICINES PROCEDURE 15: METHOTREXATE PROCEDURE REFERENCE NUMBER SABP/EXECUTIVE BOARD/0017/PROCEDURE15 PROCEDURE NAME MEDICINES PROCEDURE 15: METHOTREXATE BRIEF OUTLINE OF THIS PROCEDURE This procedure sets out the requirements for prescribing,

More information

Destruction of Narcotics, Controlled Drugs and other Targeted Substances

Destruction of Narcotics, Controlled Drugs and other Targeted Substances Destruction of Narcotics, Controlled Drugs and other Targeted Substances Pharmacists may now proceed with destruction of narcotics and/or controlled substances without requesting and receiving authorization

More information

by registered nurses employed by NHS Hertfordshire or Hertfordshire GP Practices and signatories to the PGD

by registered nurses employed by NHS Hertfordshire or Hertfordshire GP Practices and signatories to the PGD Notice to all staff: NHS Hertfordshire Patient Group Directions (PGDs) may only be used by members of the healthcare professions named on the title page and only if each professional has individually been

More information

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement.

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement. NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement May 2, 2018 1 May 2, 2018 2 Bureau Overview May 2, 2018 3 HISTORY 1850--Bureau

More information

VACCINE STORAGE AND ADMINISTRATION PROCEDURES

VACCINE STORAGE AND ADMINISTRATION PROCEDURES VACCINE STORAGE AND ADMINISTRATION PROCEDURES Document Summary To ensure vaccines are stored and administered appropriately DOCUMENT NUMBER POL/001/013/006 DATE RATIFIED January 2017 DATE IMPLEMENTED January

More information

Utah. Prescribing and Dispensing Profile. Research current through November 2015.

Utah. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Utah Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view

More information

SYRINGE DRIVERS: GUIDANCE FOR THE USE IN THE COMMUNITY and COMMUNITY HOSPITAL SETTING WITHIN WORCESTERSHIRE

SYRINGE DRIVERS: GUIDANCE FOR THE USE IN THE COMMUNITY and COMMUNITY HOSPITAL SETTING WITHIN WORCESTERSHIRE Trust Guideline SYRINGE DRIVERS: GUIDANCE FOR THE USE IN THE COMMUNITY and COMMUNITY HOSPITAL SETTING WITHIN WORCESTERSHIRE All healthcare professionals must exercise their own professional judgement when

More information

Algorithms for Symptom Management. In End of Life Care

Algorithms for Symptom Management. In End of Life Care Algorithms for Symptom Management In End of Life Care The Use of Drugs Beyond Licence (off label) -The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK regulates the activity of the

More information

PATIENT GROUP DIRECTION PROCEDURE

PATIENT GROUP DIRECTION PROCEDURE PATIENT GROUP DIRECTION PROCEDURE Date approved 2 October 2015 Version 3 Approved by Yvette Oade, Chief Medical Officer Procedure Lead Clinical Governance Lead - Medicines Management Procedure Author Karen

More information

Document ref. no: Trust Policy and Procedure. PP(16)234 Prescribing, Dispensing and Administration of Methotrexate Policy

Document ref. no: Trust Policy and Procedure. PP(16)234 Prescribing, Dispensing and Administration of Methotrexate Policy Document ref. no: Trust Policy and Procedure PP(16)234 Prescribing, Dispensing and Administration of Methotrexate Policy For use in: For use by: For use for: Document owner: Status: All Clinical Areas

More information

Care Homes - Homely Remedies Protocol

Care Homes - Homely Remedies Protocol Care Homes - Homely Remedies Protocol A homely remedy is a medicine for the short-term treatment of a minor ailment, such as indigestion, a cough, mild to moderate pain or constipation, and can be obtained

More information

The prescribing newsletter for GPs, nurses and pharmacists NHS Northamptonshire Failure to respond to first choice antibiotics

The prescribing newsletter for GPs, nurses and pharmacists NHS Northamptonshire Failure to respond to first choice antibiotics Tablet Press EXTRA The prescribing newsletter for GPs, nurses and pharmacists NHS Northamptonshire Failure to respond to first choice antibiotics March 2017 Use of Buccolam (buccal midazolam) for breakthrough

More information